Rafaèle TORDJMAN

Bio

Dr. Rafaèle Tordjman, MD PhD, has been an investor in life sciences for 20 years. She started her career at Sofinnova Partners, a Paris-based venture capital firm, in 2001, as an analyst, and became co-leader and Managing partner with €1.5 billion in assets under management. Prior to joining Sofinnova Partners, Dr. Tordjman worked as a physician and researcher in haemato-oncology. She worked at the Paris University Hospitals as a medical doctor specialising in internal medicine and clinical hematology. She completed her post-doctoral work in immunology at INSERM. In 2018, Dr. Tordjman founded Jeito Capital, an independent investment company dedicated to biopharma to invest in the next generation of leaders in medical innovation. Jeito I raised €534 million ($630 million) in September 2021, becoming the largest independent European fund in Life Sciences. In September 2020, Dr. Tordjman was awarded Chevalier de la Légion d’Honneur, France’s highest distinction. In July 2021, she was appointed by President Emmanuel Macron to promote the French biotech ecosystem among leading international players.